Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis

Table 2

Comparison of the total population with HRV vs. the population without HRV.

Variables	HRV,	Non-HRV,
Male (%)	30 (63.8)	157 (64.1)	0.974^a
Age (years)	50 (44.5-58)	53 (43-61)	0.697
BMI	22 (21.1-23.4)	23.2 (21.5-25.2)	0.126
Etiology			0.363^a
Hepatitis B	34	140
Hepatitis C	0	4
PBC	1	7
Alcohol	2	10
Others	10	83
Child-Pugh			0.291^a
A	37	208
B	10	37
Platelets (10^3/μL)	77 (57.5-96)	119 (90-169)	<0.001
ALT (IU/L)	29.3 (21-37)	26.1 (18-42)	0.465
ALB (g/L)	37.2 (33.2-40.9)	41.6 (36.8-44.4)	<0.001
Bilirubin (μM/L)	22.3 (15.5-33.2)	20 (14-28.1)	0.129
INR	1.3 (1.2-1.4)	1.2 (1.1-1.3)	<0.001
TE^† LSM (kPa)	30.1 (14-35.6)	19.6 (12-34.8)	0.405

Statistical comparison between the presence and absence of high-risk varices using Mann–Whitney test unless indicated. ^aStatistical comparison between the presence and absence of high-risk varices using Chi-square test or Fisher’s exact test. ^†TE was available in 90 patients. Abbreviations: ALB: albumin; HCV: hepatitis C virus; INR: international normalized ratio; LSM: liver stiffness measurement; PBC: primary biliary cholangitis; TE: transient elastography.